Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyrica for pain related to walking in diabetic peripheral neuropathy
NCT02927951Phase 3Completed
- Sponsor
- Eastern Virginia Medical School
- Start
- Jan 2011
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in diabetic peripheral neuropathy (DPN), sponsored by Eastern Virginia Medical School. Primary endpoint: Physiological Profile Assessment at 6 months. Started Jan 2011; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT02927951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02927951.